These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25489818)

  • 21. [Multifactorial influences on age-related macular degeneration].
    Rakic JM
    Bull Soc Belge Ophtalmol; 2006; (301):9-11. PubMed ID: 17552427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Highly penetrant alleles in age-related macular degeneration.
    den Hollander AI; de Jong EK
    Cold Spring Harb Perspect Med; 2014 Nov; 5(3):a017202. PubMed ID: 25377141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Embryonic stem cell implantation for the treatment of Stargardt’s disease and macular degeneration.
    Regen Med; 2011 Sep; 6(5):539-40. PubMed ID: 21916588
    [No Abstract]   [Full Text] [Related]  

  • 24. Age-related macular degeneration.
    Khandhadia S; Cherry J; Lotery AJ
    Adv Exp Med Biol; 2012; 724():15-36. PubMed ID: 22411231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinal pigment epithelium.
    Klimanskaya I
    Methods Enzymol; 2006; 418():169-94. PubMed ID: 17141036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transposon-Based, Targeted Ex Vivo Gene Therapy to Treat Age-Related Macular Degeneration (TargetAMD).
    Hum Gene Ther Clin Dev; 2015 Jun; 26(2):97-100. PubMed ID: 26086761
    [No Abstract]   [Full Text] [Related]  

  • 27. Firm sets sights on gene silencing to protect vision.
    Check E
    Nature; 2004 Aug; 430(7002):819. PubMed ID: 15318183
    [No Abstract]   [Full Text] [Related]  

  • 28. Human pluripotent stem cell strategies for age-related macular degeneration.
    Davidson KC; Guymer RH; Pera MF; Pébay A
    Optom Vis Sci; 2014 Aug; 91(8):887-93. PubMed ID: 24859130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-based approaches towards treating age-related macular degeneration.
    Baradaran-Rafii A; Sarvari M; Alavi-Moghadam S; Payab M; Goodarzi P; Aghayan HR; Larijani B; Rezaei-Tavirani M; Biglar M; Arjmand B
    Cell Tissue Bank; 2020 Sep; 21(3):339-347. PubMed ID: 32157501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moorfields Eye Hospital is to host European trial of human embryonic stem cells.
    Watts G
    BMJ; 2011 Sep; 343():d6124. PubMed ID: 21948878
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration.
    Lu B; Malcuit C; Wang S; Girman S; Francis P; Lemieux L; Lanza R; Lund R
    Stem Cells; 2009 Sep; 27(9):2126-35. PubMed ID: 19521979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of gene therapy for treatment of age-related macular degeneration.
    Askou AL
    Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human embryonic stem cells.
    Damdimopoulou P; Rodin S; Stenfelt S; Antonsson L; Tryggvason K; Hovatta O
    Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():2-12. PubMed ID: 26602389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rheopheresis for dry AMD: controversy requiring mutual respect.
    Klingel R
    J Clin Apher; 2005 Oct; 20(3):169-70. PubMed ID: 16106453
    [No Abstract]   [Full Text] [Related]  

  • 35. Concise Review: Making Stem Cells Retinal: Methods for Deriving Retinal Pigment Epithelium and Implications for Patients With Ocular Disease.
    Leach LL; Clegg DO
    Stem Cells; 2015 Aug; 33(8):2363-73. PubMed ID: 25809736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulatory role of HIF-1alpha in the pathogenesis of age-related macular degeneration (AMD).
    Arjamaa O; Nikinmaa M; Salminen A; Kaarniranta K
    Ageing Res Rev; 2009 Oct; 8(4):349-58. PubMed ID: 19589398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rare genetic variants in Tunisian Jewish patients suffering from age-related macular degeneration.
    Pras E; Kristal D; Shoshany N; Volodarsky D; Vulih I; Celniker G; Isakov O; Shomron N; Pras E
    J Med Genet; 2015 Jul; 52(7):484-92. PubMed ID: 25986072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammation and the pathogenesis of age-related macular degeneration.
    Augustin AJ; Kirchhof J
    Expert Opin Ther Targets; 2009 Jun; 13(6):641-51. PubMed ID: 19456269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment.
    Cheung CM; Wong TY
    J Intern Med; 2014 Aug; 276(2):140-53. PubMed ID: 24581182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of HTRA1 polymorphism and bilaterality in advanced age-related macular degeneration.
    Chen H; Yang Z; Gibbs D; Yang X; Hau V; Zhao P; Ma X; Zeng J; Luo L; Pearson E; Constantine R; Kaminoh Y; Harmon J; Tong Z; Stratton CA; Cameron DJ; Tang S; Zhang K
    Vision Res; 2008 Feb; 48(5):690-4. PubMed ID: 18206206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.